MUSCLE, GROWTH & RECOVERY

Ipamorelin/CJC-1295

A synergistic blend of two growth-hormone-releasing peptides studied for recovery, sleep, and body composition.

This is a research blend of two complementary growth-hormone-releasing peptides—Ipamorelin (a clean GHRP) and CJC-1295 without DAC (a long-acting GHRH). Together they are studied for fat loss, muscle recovery, sleep quality, and anti-aging markers, and the combination has a long, widespread research-use history.

GHRP + GHRH BlendRecoveryDeep SleepBody Composition

Why BLP features Ipamorelin/CJC-1295

Included because it combines a well-characterized dual GH-release mechanism with one of the longest and most consistent research-use histories among GH-axis peptides. Human trial evidence on the specific blend is limited, but its established use and mechanistic clarity make it a research staple.

Mechanism

Ipamorelin stimulates a natural GH pulse without cortisol or prolactin spikes.

CJC-1295 (no DAC) extends the GH-release window to several hours.

Together they are described as producing a higher-amplitude GH pulse than either peptide alone.

WHAT THE RESEARCH MEASURED

Research findings

Findings describe study outcomes, not expected personal results.

Human research findings

  • Reported increased fat loss, particularly abdominal.
  • Reported faster recovery and lean muscle gains, with deeper sleep and improved morning energy.
  • Reported better skin elasticity and hair quality.
  • Reported IGF-1 elevation within the normal physiological range. Side effects were very mild—occasional water retention or flushing at higher doses.

Preclinical findings

  • Individual GHRP and GHRH mechanisms are well characterized.
  • Synergistic GH-pulse amplification modeled from the combined pharmacology.

Regulatory status

The individual peptides are investigational; the blend is offered strictly for laboratory and research use and is not FDA-approved.